Clinical trials show progress in migraine frequency, skin cancer prevention
-
3:22
Blind Milwaukee man inspires community with his uplifting music
-
6:28
An in-depth look at the Milwaukee Public Museum’s transition...
-
1:08
Milwaukee kids take first flights in event honoring slain rapper...
-
0:28
Alma Center Lincoln senior football player dies after injury...
-
1:47
Person seriously injured in Milwaukee shooting near 41st and...
-
0:52
HeartLove Place hosts 26th annual back-to-school giveaway in...
-
0:36
Fond du Lac County Sheriff’s Office mourns unexpected death...
-
0:59
Black Business Market highlights local entrepreneurs in Milwaukee’s...
-
0:20
One person taken to hospital following motorcycle crash in Walker’s...
-
0:43
3 injured after SUV fails to yield, strikes semi in Dodge County
-
2:34
Saturday’s Schlesinger Showcase (8/22)...Mexican Fiesta, Zoo...
-
2:57
Still no searing heat along with a few rain chances this coming...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.